Old Drugs, New Indications (Review)
Introduction. The drug can be used in the treatment of one disease and for the prevention and treatment of another pathological process. This is possible due to the repurposing of medicines. Creating drugs from scratch takes a long time to develop and implement, which leads to large financial costs,...
Saved in:
Main Authors: | I. I. Miroshnichenko, E. A. Valdman, I. I. Kuz'min |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2023-02-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/1448 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THERAPEUTIC DRUG MONITORING OF LAMOTRIGINE: DEVELOPMENT OF PHARMACOKINETIC APPROACHES AIMING AT THE INDIVIDUAL-BASED ANTICONVULSIVE PHARMACOTHERAPY
by: D. A. Abaimov, et al.
Published: (2016-05-01) -
NEW METHODS OF OPTIMIZATION OF EPILEPSY PHARMACOTHERAPY: USE OF BAYESIAN PHARMACOKINETIC MODELING
by: Z. А. Suslina, et al.
Published: (2016-09-01) -
Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study
by: Kathrin Marx, et al.
Published: (2025-05-01) -
Risk of End-Stage Kidney Disease and Topiramate Use
by: Jean-Michel Halimi, et al.
Published: (2025-08-01) -
Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients
by: Alessandro Mancini, et al.
Published: (2025-07-01)